Endometriose in der Peri- und Postmenopause

In: Gynäkologische Endokrinologie · 2019 · vol. 17(2) , pp. 114–116 · doi:10.1007/s10304-019-0249-8 · W2937887691
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-12

This literature review examines endometriosis in peri- and postmenopausal women, referencing studies on age patterns, recurrence with hormone therapy, and management strategies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

This short German-language article reviews existing literature on endometriosis around the peri- and postmenopausal periods, drawing on studies examining incidence patterns and recurrence after surgery, hormone replacement therapy after hysterectomy/oophorectomy, and systematic review evidence for menopause management in women with a history of endometriosis. It highlights that menopause-related hormonal changes intersect with endometriosis course, including data on age patterns and on recurrence risk when hormone therapy is used, while also noting that broader management questions have been addressed in reviews of both medical and surgical approaches and by perimenopausal risk discussions. A key limitation is that the piece itself does not present new empirical data and summarizes heterogeneous prior studies rather than conducting an original analysis. Relevance to endometriosis: it is centrally about endometriosis in the peri- and postmenopause, explicitly synthesizing evidence related to endometriosis across these life stages.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 2,372 characters · extracted from oa-doi-fallback · click to expand
Literatur Haas et al (2012) Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Arch Gynecol Obstet 286(3):667–670 Matorras R et al (2002) Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril 77:303–308 Rattanachaiyanont M et al (2003) Hormonal replacement therapy in surgical menopause with underlying endometriosis. J Med Assoc Thai 86:702–707 Hickman TN et al (1998) Timing of estrogen replacement therapy following hysterectomy with oophorectomy for endometriosis. Obstet Gynecol 91(5 Pt 1):673–677 Gemmel KE et al (2017) The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update 23(4):481–500 Vercellini et al (2018) Perimenopausal management of ovarian endometriosis and related cancer risk: when is medical or surgical treatment indicated? Best Pract Res Clin Obstet Gynaecol 51:151–168. https://doi.org/10.1016/j.bpobgyn.2018.01.017 Alio et al (2019) Endometriosis: seeking optimal management in women approaching menopause. Climacteric. https://doi.org/10.1080/13697137.2018.1549213 Vercellini et al (2008) Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 198(5):504.e1–504.e5 Morelli M et al (2013) Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis: a retrospective study. Gynecol Endocrinol 29:305–308 Author information Authors and Affiliations Corresponding author Ethics declarations Interessenkonflikt Q. Le, S. Franik, S.D. Schäfer und L. Kiesel geben an, dass kein Interessenkonflikt besteht. Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Additional information Redaktion L. Kiesel, Münster A.O. Mueck, Tübingen P. Stute, Bern Rights and permissions About this article Cite this article Le, Q., Franik, S., Schäfer, S.D. et al. Endometriose in der Peri- und Postmenopause. Gynäkologische Endokrinologie 17, 114–116 (2019). https://doi.org/10.1007/s10304-019-0249-8 Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s10304-019-0249-8

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK